These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Induction therapies with polyclonal antithymocyte globulins or monoclonal antibodies. Charpentier B; Hiesse C; Marchand S; Boubenider S; Ammor M; Kechrid C; Benoit G; Durrbach A Transplant Proc; 2000 Mar; 32(2):367. PubMed ID: 10715442 [No Abstract] [Full Text] [Related]
4. Comparison of quadruple immunosuppression after liver transplantation with ATG or IL-2 receptor antibody. Neuhaus P; Bechstein WO; Blumhardt G; Wiens M; Lemmens P; Langrehr JM; Lohmann R; Steffen R; Schlag H; Slama KJ Transplantation; 1993 Jun; 55(6):1320-7. PubMed ID: 8516819 [TBL] [Abstract][Full Text] [Related]
5. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients. Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178 [TBL] [Abstract][Full Text] [Related]
6. Early rejection prophylaxis in heart transplantation: is cytolytic therapy necessary? Renlund DG; O'Connell JB; Bristow MR J Heart Transplant; 1989; 8(3):191-3. PubMed ID: 2661767 [No Abstract] [Full Text] [Related]
7. Introduction to the management of immunosuppression. Council on Scientific Affairs. JAMA; 1987 Apr; 257(13):1781-5. PubMed ID: 3546758 [TBL] [Abstract][Full Text] [Related]
8. Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression. Trzonkowski P; Zilvetti M; Friend P; Wood KJ Transplantation; 2006 Nov; 82(10):1342-51. PubMed ID: 17130784 [TBL] [Abstract][Full Text] [Related]
9. Induction therapy: why, when, and which agent? Krischock L; Marks SD Pediatr Transplant; 2010 May; 14(3):298-313. PubMed ID: 20345609 [TBL] [Abstract][Full Text] [Related]
10. Use of monoclonal antibodies in renal transplantation. van den Hoogen MW; Hilbrands LB Immunotherapy; 2011 Jul; 3(7):871-80. PubMed ID: 21751955 [TBL] [Abstract][Full Text] [Related]
11. Immunosuppression and tolerance for clinical organ allografts. Monaco AP Curr Opin Immunol; 1989 Aug; 1(6):1174-7. PubMed ID: 2679755 [No Abstract] [Full Text] [Related]
15. [Monoclonal antibodies in organ transplantation]. Vanhove B Med Sci (Paris); 2009 Dec; 25(12):1121-5. PubMed ID: 20035690 [TBL] [Abstract][Full Text] [Related]
16. Anti-CD4 monoclonal antibodies in therapy: creation of nonclassical tolerance in the adult. Shizuru JA; Alters SE; Fathman CG Immunol Rev; 1992 Oct; 129():105-30. PubMed ID: 1361179 [No Abstract] [Full Text] [Related]
17. Nursing implications of immunosuppression in transplantation. Shaefer M; Williams L Nurs Clin North Am; 1991 Jun; 26(2):291-314. PubMed ID: 1904575 [TBL] [Abstract][Full Text] [Related]
18. Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy. McCurry KR; Iacono A; Zeevi A; Yousem S; Girnita A; Husain S; Zaldonis D; Johnson B; Hattler BG; Starzl TE J Thorac Cardiovasc Surg; 2005 Aug; 130(2):528-37. PubMed ID: 16077423 [TBL] [Abstract][Full Text] [Related]
19. Use of antibody induction in pediatric renal transplantation. Pescovitz MD Curr Opin Organ Transplant; 2008 Oct; 13(5):495-9. PubMed ID: 19060532 [TBL] [Abstract][Full Text] [Related]
20. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement. Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]